Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024

Date: February 27, 2019
Pages: 128
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EF0A7A4F26FEN
Leaflet:

Download PDF Leaflet

Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024
“High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products market”

The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market to a certain extent in the coming years.

“The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period”

Based on end user, the exosomes research products market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to significant investments by companies in research activities for the development of exosome-based diagnostics to combat new diseases.

“The lung cancer segment accounted for the largest share of the exosome research products market during the forecast period”

Based on cancer applications, the exosomes research products market is segmented into lung, prostate, breast, colorectal, and other cancers. In 2018, lung cancer accounted for the largest share of the exosomes market for cancer applications. The large share of this segment can primarily be attributed to factors such as the increasing prevalence of lung cancer, technological advancements in instruments & assays for liquid biopsy, and the growing demand for advanced diagnostic technologies.

“North America to dominate the market during the forecast period”

In 2018, North America accounted for the largest share of the exosome research products market. The North American market is also expected to grow at the highest CAGR during the forecast period. Factors such as the availability of government funding for life science research, favorable regulatory environment, increasing focus on exosomes in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research are driving the growth of the exosomes market in North America. According to R&D Magazine (2018), North America accounted for 27.36% of global R&D spending. North America has several national institutes that support biotechnology and life science research activities. The growth of the biotechnology and pharmaceutical industries and growth in the number of cancer cases in the region are also supporting market growth.

The primary interviews conducted for this report can be categorized as follows:
  • By Company Type: Tier 1 (55%), Tier 2 (20%), and Tier 3 (25%)
  • By Designation: C-level (58%), D-level (19%), and Others (23%)
  • By Region: North America (40%), Europe (30%), Asia (10%), and RoW (20%)
List of Companies Profiled in the Report
  • Thermo Fisher Scientific (US)
  • QIAGEN N.V. (Netherlands)
  • Lonza (Switzerland)
  • Bio-Techne (US)
  • System Biosciences, LLC. (US)
  • NX Pharmagen (US)
  • Miltenyi Biotec (Germany)
  • AMS Biotechnology (Europe) Limited (UK)
  • NanoSomiX (US)
  • Norgen Biotek Corp. (Canada)
Research Coverage:

This report provides a detailed picture of the global exosome research products market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research products market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKET COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 EXOSOMES MARKET: OVERVIEW
4.2 EXOSOMES MARKET, BY APPLICATION, 2019–2024 (USD MILLION)
4.3 EXOSOME MARKET SHARE, BY CANCER APPLICATIONS & REGION (2018)
4.4 EXOSOME MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
4.5 EXOSOME MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Increasing funding for life sciences research
    5.2.1.2 High global prevalence of cancer
    5.2.1.3 Increasing interest in exosome-based procedures
  5.2.2 RESTRAINTS
    5.2.2.1 Lack of skilled professionals
  5.2.3 OPPORTUNITIES
    5.2.3.1 Untapped emerging markets
    5.2.3.2 Growing interest in exosome-based therapeutics
    5.2.3.3 Personalized medicine

6 EXOSOMES MARKET, BY PRODUCT & SERVICE

6.1 INTRODUCTION
6.2 KITS AND REAGENTS
  6.2.1 KITS AND REAGENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE EXOSOMES MARKET DURING THE FORECAST PERIOD
6.3 INSTRUMENTS
  6.3.1 INCREASE IN THE NUMBER OF DIAGNOSTIC LABORATORIES OFFERING EXOSOME-BASED TESTS TO DRIVE THE ADOPTION OF INSTRUMENTS
6.4 SERVICES
  6.4.1 EXOSOME SERVICES AID ONCOLOGISTS TO DETECT AND MONITOR CANCER BIOMARKERS FROM A SIMPLE BLOOD OR URINE SAMPLE

7 EXOSOMES MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 CANCER APPLICATIONS
  7.2.1 LUNG CANCER
    7.2.1.1 Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth
  7.2.2 BREAST CANCER
    7.2.2.1 High prevalence of breast cancer and increasing awareness to drive the market for this segment
  7.2.3 PROSTATE CANCER
    7.2.3.1 Liquid biopsy helps detect aggressive prostate cancer before surgery—a key factor driving market growth
  7.2.4 COLORECTAL CANCER
    7.2.4.1 Increasing research activities and projects based on exosomes to drive the market for this segment
  7.2.5 OTHER CANCERS
    7.2.5.1 Rising incidence of cancer and increasing research funding to drive the market for this segment
7.3 NON-CANCER APPLICATIONS
  7.3.1 WIDE RANGE OF NON-CANCER APPLICATIONS TO DRIVE GROWTH IN THE DEMAND FOR EXOSOMES IN THIS APPLICATION SEGMENT

8 EXOSOMES MARKET, BY END USER

8.1 INTRODUCTION
8.2 ACADEMIC & RESEARCH INSTITUTES
  8.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN THE EXOSOMES MARKET
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  8.3.1 SIGNIFICANT DEVELOPMENTS IN RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT
8.4 HOSPITALS & CLINICAL TESTING LABORATORIES
  8.4.1 HOSPITALS & CLINICAL TESTING LABORATORIES USE EXOSOMES FOR THE DIAGNOSIS OF CANCER

9 EXOSOMES MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
  9.2.1 US
    9.2.1.1 High burden of cancer and favorable public and private funding for research activities to drive market growth
  9.2.2 CANADA
    9.2.2.1 Availability of research funding & rising incidence of cancer to drive market growth
9.3 EUROPE
  9.3.1 GERMANY
    9.3.1.1 Presence of a large number of academic research institutes to support market growth
  9.3.2 UK
    9.3.2.1 Growth in the life sciences industry to drive the market for exosomes in the UK
  9.3.3 FRANCE
    9.3.3.1 Government initiatives to boost R&D activities in the country and high healthcare expenditure are the key factors driving market growth
  9.3.4 ROE
9.4 ASIA
  9.4.1 CHINA
    9.4.1.1 Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are the major factors driving market growth
  9.4.2 JAPAN
    9.4.2.1 High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosomes market in the country
  9.4.3 REST OF ASIA
9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE SCENARIO
  10.3.1 PARTNERSHIPS AND AGREEMENTS (2016–2019)
  10.3.2 PRODUCT LAUNCHES (2016–2019)
  10.3.3 ACQUISITIONS (2016–2019)
  10.3.4 EXPANSIONS (2016–2019)
10.4 COMPETITIVE LEADERSHIP MAPPING (2017)
  10.4.1 VANGUARDS
  10.4.2 INNOVATORS
  10.4.3 DYNAMIC PLAYERS
  10.4.4 EMERGING PLAYERS

11 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

11.1 BIO-TECHNE
11.2 THERMO FISHER SCIENTIFIC INC.
11.3 SYSTEM BIOSCIENCES (SBI)
11.4 NX PHARMAGEN
11.5 QIAGEN N.V.
11.6 MILTENYI BIOTECH
11.7 AMS BIOTECHNOLOGY LTD.
11.8 NANOSOMIX
11.9 LONZA GROUP AG
11.10 NORGEN BIOTEK CORP.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX

12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
LIST OF TABLES

TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 2 EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 3 EXOSOMES MARKET FOR KITS AND REAGENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 4 EXOSOMES MARKET FOR INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 EXOSOMES MARKET FOR SERVICES, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 7 EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 8 EXOSOMES MARKET FOR CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 EXOSOMES MARKET FOR LUNG CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 EXOSOMES MARKET FOR BREAST CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 EXOSOMES MARKET FOR PROSTATE CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 EXOSOMES MARKET FOR COLORECTAL CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 EXOSOMES MARKET FOR OTHER CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 EXOSOMES MARKET FOR NON-CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 16 EXOSOMES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 EXOSOMES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 EXOSOMES MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 EXOSOMES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: EXOSOMES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 NORTH AMERICA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 22 NORTH AMERICA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 25 US: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 26 US: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27 US: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 28 US: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 29 CANADA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 30 CANADA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 31 CANADA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 32 CANADA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 33 EUROPE: EXOSOMES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 35 EUROPE: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 EUROPE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 38 GERMANY: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 39 GERMANY: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 40 GERMANY: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 41 GERMANY: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 42 UK: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 43 UK: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 44 UK: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 45 UK: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 FRANCE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 47 FRANCE: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 FRANCE: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 ROE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 51 ROE: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 52 ROE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 53 ROE: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 54 ASIA: EXOSOMES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 55 ASIA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 56 ASIA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 ASIA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 58 ASIA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 59 CHINA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 60 CHINA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 61 CHINA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 CHINA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 63 JAPAN: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 64 JAPAN: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 65 JAPAN: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 JAPAN: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 67 ROA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 68 ROA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 69 ROA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 70 ROA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71 ROW: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 72 ROW: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 73 ROW: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 ROW: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION)
LIST OF FIGURES

FIGURE 1 EXOSOMES MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 EXOSOMES MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 EXOSOMES MARKET, BY APPLICATION, 2019 (USD MILLION)
FIGURE 9 EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 10 EXOSOMES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE EXOSOMES MARKET
FIGURE 12 HIGH GLOBAL BURDEN OF CANCER & INCREASING FUNDING FOR LIFE SCIENCE RESEARCH ARE DRIVING THE GROWTH OF THE EXOSOME MARKET
FIGURE 13 NON-CANCER APPLICATION SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 14 LUNG CANCER SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES TO HOLD THE LARGEST SHARE OF THE EXOSOME MARKET DURING THE FORECAST PERIOD
FIGURE 16 NORTH AMERICA IS THE FASTEST-GROWING REGION IN THE EXOSOME MARKET
FIGURE 17 EXOSOMES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 18 KITS AND REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE EXOSOME PRODUCTS MARKET DURING THE FORECAST PERIOD
FIGURE 19 CANCER APPLICATIONS SEGMENT TO DOMINATE EXOSOMES MARKET DURING THE FORECAST PERIOD (2019–2024)
FIGURE 20 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 21 NORTH AMERICA: EXOSOMES MARKET SNAPSHOT
FIGURE 22 US: CANCER STATISTICS
FIGURE 23 CANADA: CANCER STATISTICS
FIGURE 24 EUROPE: EXOSOMES MARKET SNAPSHOT
FIGURE 25 ASIA: EXOSOMES MARKET SNAPSHOT
FIGURE 26 ROW: EXOSOMES MARKET SNAPSHOT
FIGURE 27 KEY DEVELOPMENTS IN THE EXOSOMES MARKET (JAN 2016-JAN 2019)
FIGURE 28 MARKET EVOLUTION FRAMEWORK
FIGURE 29 EXOSOMES MARKET RANKING ANALYSIS, BY KEY PLAYER (2017)
FIGURE 30 MNM DIVE-VENDOR COMPARISON MATRIX: EXOSOMES MARKET
FIGURE 31 COMPANY SNAPSHOT: BIO-TECHNE
FIGURE 32 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC
FIGURE 33 COMPANY SNAPSHOT: QIAGEN N.V.
FIGURE 34 LONZA GROUP AG: COMPANY SNAPSHOT
Skip to top


Ask Your Question

Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: